DRX DLY S&P Biotech Bull 3XETF

13F holders, Q1 2024 (March 31)
3holders
$131.83avg. 13F price*

At the end of Q1 2024, 3 institutions reported holding DRX DLY S&P Biotech Bull 3X in their 13F filings. The largest holders were Parallel Advisors, LLC ($130K), Lindbrook Capital, LLC ($7K) and Cornerstone Planning Group LLC ($4K).

Company
DRX DLY S&P Biotech Bull 3X
Filed as
DIREXION DAILY S&P BIOTECH BULL 3X SHARES (Q1 2024)
CUSIP
25490K323
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246 Q1 2024: 3Q1 2024Q2 2024: 5Q2 2024Q3 2024: 4Q3 2024Q4 2024: 6Q4 2024Q1 2025: 6Q1 2025Q2 2025: 5Q2 2025Q3 2025: 5Q3 2025Q4 2025: 4Q4 2025Q1 2026: 4Q1 2026Q2 2026: 4Q2 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions1$7K
Exits3$389K

Ownership 3 holders

Parallel Advisors, LLC 0.00% Reduce -44.2% 980 $130K
Lindbrook Capital, LLC 0.00% New 50 $7K
Cornerstone Planning Group LLC 0.00% Add +2.9% 36 $4K

"% of holder's portfolio" is DRX DLY S&P BIOTECH BULL 3X's weight in each manager's 13F, not the share of DRX DLY S&P Biotech Bull 3X the manager owns.